Objective
to compare the 5-year clinical outcomes of biodegradable polymer sirolimus-eluting stent O-SES with a durable polymer everolimus-eluting stent X-EES
Study
multicentre 2:1 non-inferiority randomised trial
Population
patients with stable angina
Endpoints
TLF as a composite cardiac death, target vessel MI and clinically driven TLR at 5 years
Conclusion
the biodegradable polymer SES was associated with similar 5-year adverse events compared to durable polymer EES
Lefevre et al. J Am Coll Cardiol Intv. 2018;11:995-1002
